Genfit and LabCorp team up to develop NASH diagnostic tests

One of the most difficult challenges with NASH is that it is so difficult to diagnose. While many Biotech companies are working hard to develop a cure for NASH, some are also busy developing new innovative methods to detect NASH without requiring an invasive liver biopsy.

Genfit is one of the few companies due to release Phase 3 trials of NASH treatments in 2019. Not content with focusing merely on a cure, they are also nearing completion of trials on a new blood test for earlier detection of NASH. They have just recently announced a partnership with LabCorp, which will allow them access to a much wider audience for the clinical research required to validate the new test.

Continue reading “Genfit and LabCorp team up to develop NASH diagnostic tests”

2019: The Year of NASH

2018 was a big year for those trying to raise awareness of NASH, as well as those developing treatments and diagnostic methods. The first International NASH Day was held, a day of action with events in over a dozen cities on four continents.

2019 is already looking to be a major year for progress in the fight against NASH. Recently, Goldman Sachs declared that 2019 will be “The Year of NASH” based on the fact that several BioTech companies are expected to release late-stage trial results of promising treatments.

Continue reading “2019: The Year of NASH”

Support the ALF Honors Gala tonight!

Tonight I’m attending the ALF Honors Gala in my capacity as a Board Member and the chair of the Associate Board for the Greater New York Division. The Gala is an annual fundraiser that honors influential professionals, physicians, and business leaders in our community.

It also just happens to be Giving Tuesday! Here are some ways you can show your support:

Bid on one of our GNY Honors Gala auction items. With over 70 items to choose from, there is something for everyone! Click here to view all items.

Make a donation to one of our honorees – Did you know that Dr. Ayşe Aytaman is the first FEMALE to receive the Physician of the Year Award?

Show your support today!

Have TWO friends? Chances are, one of you has a Fatty Liver.

This headline sounds like hysteria, but the sobering reality is that nearly a third of the population of the USA has NAFLD.  This is just one of the many facts presented on this outstanding NASH brochure.  I love the simplicity of the Q&A nature of this factoid, and have been speaking with the author, Tony Villiotti.

Tony is a NASH transplant survivor and the founder of the NASH Education Corporation, a Pittsburgh-based non-profit focusing on increasing awareness and providing educational materials for NASH.  I’ve been wanting to write about patients living with NASH for quite some time and Tony was generous enough to agree to an interview for a profile piece, the first ever on NASH AWARE.

NASHEd Page 1
One of Tony’s goals is to get this brochure placed in health care locations, health fairs, and other places where it can reach a wide audience.

Continue reading “Have TWO friends? Chances are, one of you has a Fatty Liver.”

Modest alcohol consumption may REDUCE mortality in patients with NAFLD

A new study from New York Presbyterian Hospital has some eyebrow-raising findings.  We already know that drinking coffee is good for the liver, but you would expect to find less evidence of a positive relationship with alcohol.  Yes, there have been plenty of studies that show a glass of wine can be good for you, but never one that highlighted an actual positive link.

This study goes even further and finds that moderate drinking can actually lead to a reduced mortality risk in patients with NAFLD.  Wut??? Continue reading “Modest alcohol consumption may REDUCE mortality in patients with NAFLD”

A Star in the Sky: Coping with the sudden loss of a loved one

My mother passed away suddenly four years ago this month after a short battle with late-stage NASH.  Which is impossible, but somehow true.  Just a few days before being diagnosed with NASH she was celebrating with my wife and I at a housewarming party at the Shore.  A picture of her from that party occupies a prominent place on our fridge; the last picture of her before our lives were all changed forever.

mom pic
Mom just a few days before she fell into a coma as a result of liver failure.

Continue reading “A Star in the Sky: Coping with the sudden loss of a loved one”

Viking Therapeutics delivers promising results in NALFD trial

It’s another promising result from one of the dozens of bio-pharmaceutical companies trying to find treatments for fatty liver disease.  Viking Therapeutics announced results from an early study of NAFLD patients that exceeded expectations yesterday, sending the stock soaring 122%.

trial Continue reading “Viking Therapeutics delivers promising results in NALFD trial”

The Thyroid’s link to NASH

I lost my mother suddenly to late-stage NASH when she was only 62 years old.  The search for answers and meaning has led me to working with the American Liver Foundation and starting this blog.  One thing that has become increasingly clear to me was that my mom’s decades of hypothyroidism could have been a major cause of her progression to NASH.  Now, a new meta-study examining 18 years of data has concluded that those patients with primary hypothyroidism are at a 42% increased risk for developing NAFLD, the precursor to NASH. Continue reading “The Thyroid’s link to NASH”

New treatment restarts liver regeneration

One of the coolest things about the liver is that it is the only major organ capable of regenerating itself.  In fact, during a living donor liver transplant, as little as 1/3 of the living donor’s liver is transplanted and grows back to full size in the recipient within only a few weeks time.  When you think about it, this makes perfect sense.  The liver’s job is to detoxify our bodies, which means that they are constantly processing toxins that would otherwise kill us.  Whether it is alcohol, drugs, or simple byproducts of food that we ingest, the liver has to be able to handle removing them from our bloodstream to keep us healthy.   Continue reading “New treatment restarts liver regeneration”